A century of safety: Aluminium vaccine adjuvants do not raise serious long-term health risks

	Asthma
	The latest asthma news from News Medical

	A century of safety: Aluminium vaccine adjuvants do not raise serious long-term health risks A BMJ systematic review of 59 human studies found no evidence supporting causal links between aluminum-adjuvanted vaccines and serious or long-term outcomes such as autism spectrum disorder, asthma, autoimmune conditions, or other chronic illnesses. The most consistent adverse events were uncommon, local, self-limited persistent nodules or granulomas, likely reflecting delayed-type hypersensitivity.

	Slow and steady wins: Low-dose peanut immunotherapy safely desensitizes 82% of preschoolers in landmark trial A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of preschool children achieve sustained peanut tolerance after three years. The approach proved safer than conventional protocols, with severe reactions uncommon and strong family adherence throughout treatment.

			Nighttime heat waves linked to asthma emergency room visits in Baltimore Hospitals in Baltimore see an uptick in asthma-related emergency room cases in the weeks following nighttime heat waves in their neighboring communities, according to new research from Johns Hopkins University.

			Asthma-Friendly Schools recognition program expands across Colorado districts A total of 221 schools across early childhood, elementary, middle and high school levels have earned Colorado Asthma-Friendly School recognition.

			Shaping the future of asthma management with the NObreath® at ATS 2026 World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device at booth 1236 alongside its US distributor coVita™.

	Asthma medication formoterol shows promise for treating fatty liver disease MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide.

	New initiative aims to tackle bronchiectasis underdiagnosis in America The American Thoracic Society (ATS) today announced a major quality improvement initiative aimed at tackling the persistent and widespread underdiagnosis of bronchiectasis in the United States.

	Extensive data analysis confirms the safety of aluminum adjuvanted vaccines Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long-term health outcomes, including autism, diabetes, and asthma, finds a review of the latest data published by The BMJ today.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026